# Thyme Care

> Thyme Care partners with payers and providers on value-based oncology navigation and care management.

## Why it is interesting

Cancer care coordination is a proven VBC wedge; a16z Bio+Health backed through unicorn Series D as Thyme manages $5B+ in oncology spend.

## Profile

- **Stage:** other
- **Status:** private
- **Industries:** healthtech, biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series C (Jul 2024): $55M equity; a16z Bio+Health among existing investors — Thyme Care blog
- Series D (Sep 2025): $97M; CVS Health Ventures, a16z Bio+Health, AlleyCorp participated — Fierce Healthcare
- Value-based oncology navigation platform

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/alleycorp

---
Source: https://venturecapitaltracker.com/startup/thyme-care